BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20664060)

  • 1. Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.
    Nishiwaki S; Inamoto Y; Sakamaki H; Kurokawa M; Iida H; Ogawa H; Fukuda T; Ozawa Y; Kobayashi N; Kasai M; Mori T; Iwato K; Yoshida T; Onizuka M; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Miyamura K
    Blood; 2010 Nov; 116(20):4368-75. PubMed ID: 20664060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission.
    Nishiwaki S; Terakura S; Yasuda T; Imahashi N; Sao H; Iida H; Kamiya Y; Niimi K; Morishita Y; Kohno A; Yokozawa T; Ohashi H; Sawa M; Kodera Y; Miyamura K
    Int J Hematol; 2010 Apr; 91(3):419-25. PubMed ID: 20146028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Nishiwaki S; Miyamura K; Ohashi K; Kurokawa M; Taniguchi S; Fukuda T; Ikegame K; Takahashi S; Mori T; Imai K; Iida H; Hidaka M; Sakamaki H; Morishima Y; Kato K; Suzuki R; Tanaka J;
    Ann Oncol; 2013 Jun; 24(6):1594-602. PubMed ID: 23372050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lyu M; Jiang E; He Y; Yang D; Ma Q; Pang A; Zhai W; Wei J; Huang Y; Zhang G; Zhang R; Feng S; Han M
    Hematology; 2021 Dec; 26(1):65-74. PubMed ID: 33402056
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
    Nishiwaki S; Sugiura I; Fujisawa S; Hatta Y; Atsuta Y; Doki N; Kurahashi S; Ueda Y; Dobashi N; Maeda T; Matsumura I; Tanaka M; Kako S; Ichinohe T; Fukuda T; Ohtake S; Ishikawa Y; Miyazaki Y; Kiyoi H;
    Am J Hematol; 2024 May; 99(5):806-815. PubMed ID: 38314662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
    Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission.
    Kaito S; Kurosawa S; Najima Y; Sakaida E; Shingai N; Fukuda T; Tachibana T; Uchida N; Ozawa Y; Sawa M; Nakazawa H; Ota S; Kato J; Nakamae H; Katayama Y; Eto T; Tanaka J; Kanda Y; Atsuta Y; Arai Y; Kako S;
    Transplant Cell Ther; 2022 Jun; 28(6):326.e1-326.e10. PubMed ID: 35306218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.
    Czerw T; Labopin M; Giebel S; Socié G; Volin L; Fegueux N; Masszi T; Blaise D; Chaganti S; Cornelissen JJ; Passweg J; Maertens J; Itälä-Remes M; Wu D; Mohty M; Nagler A
    Cancer; 2018 Jun; 124(12):2523-2533. PubMed ID: 29603136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Nishiwaki S; Miyamura K
    Leuk Lymphoma; 2012 Apr; 53(4):550-6. PubMed ID: 21854085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
    Hwang YY; Mohty M; Chim CS
    Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
    Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic stem cell transplantation in CR1 as the front-line therapy for adult Ph(+) acute lymphoblastic leukemia].
    Huang J; Zou DH; Fu MW; Li ZJ; Xu Y; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):673-8. PubMed ID: 22339825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia.
    Bakr M; Rasheed W; Mohamed SY; Al-Mohareb F; Chaudhri N; Al-Sharif F; Al-Zahrani H; Al-Dawsari G; Saleh AJ; Nassar A; Ahmed S; Elghazaly A; Ahmed SO; Ibrahim K; Chebbo W; El Gohary GM; Al Mahayni MH; Hussain F; Nurgat Z; Elhassan TA; Walter CU; Aljurf M
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1897-904. PubMed ID: 22824185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
    Cornelissen JJ; van der Holt B; Verhoef GE; van't Veer MB; van Oers MH; Schouten HC; Ossenkoppele G; Sonneveld P; Maertens J; van Marwijk Kooy M; Schaafsma MR; Wijermans PW; Biesma DH; Wittebol S; Voogt PJ; Baars JW; Zachée P; Verdonck LF; Löwenberg B; Dekker AW;
    Blood; 2009 Feb; 113(6):1375-82. PubMed ID: 18988865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
    Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
    Zhang M; Fu H; Lai X; Tan Y; Zheng W; Shi J; Zhao Y; Lin M; He J; Cai Z; Luo Y; Huang H
    PLoS One; 2016; 11(10):e0163599. PubMed ID: 27695097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1.
    Lv M; Jiang Q; Zhou DB; Hu Y; Liu DH; Wu DP; Wang JB; Jiang H; Wang J; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    J Hematol Oncol; 2020 May; 13(1):52. PubMed ID: 32414392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience.
    Jamieson CH; Amylon MD; Wong RM; Blume KG
    Exp Hematol; 2003 Oct; 31(10):981-6. PubMed ID: 14550815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.